Single pot organic solvent-free thermocycling technology for siRNA-ionizable LNPs: a proof-of-concept approach for alternative to microfluidics

References

• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. (2006). Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 58:1688–713.
   PubMed Web of Science ®Google Scholar
• Agency EM. Summary of product characteristics: Onpattro 2 mg/mL concentrate for solution for infusion. 2018.
   Google Scholar
• Akinc A, Maier MA, Manoharan M, et al. (2019). The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat Nanotechnol 14:1084–7.
   PubMed Web of Science ®Google Scholar
• Alnylam Pharmaceuticals I. (2018). Alnylam Announces First-Ever FDA Approval of an RNAi Therapeutic, ONPATTRO™(patisiran) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults. Cambridge (MA): Alnylam Pharmaceuticals Press.
   Google Scholar
• Alzorqi I, Ketabchi MR, Sudheer S, Manickam S. (2016). Optimization of ultrasound induced emulsification on the formulation of palm-olein based nanoemulsions for the incorporation of antioxidant β-d-glucan polysaccharides. Ultrason Sonochem 31:71–84.
   PubMed Web of Science ®Google Scholar
• Bakhtiar A, Neah AS, Ng KY, Chowdhury EH. (2022). In vivo evaluation of biodistribution and toxicity of pH-responsive strontium nanoparticles for gene delivery. J Pharm Investig 52:95–107.
   Web of Science ®Google Scholar
• Ball RL, Bajaj P, Whitehead KA. (2017). Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization. Int J Nanomedicine 12:305–15.
   PubMed Web of Science ®Google Scholar
• Blakney AK, McKay PF, Yus BI, et al. (2019). Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA. Gene Ther 26:363–72.
   PubMed Web of Science ®Google Scholar
• Buyens K, Demeester J, De Smedt SS, Sanders NN. (2009). Elucidating the encapsulation of short interfering RNA in PEGylated cationic liposomes. Langmuir 25:4886–91.
   PubMed Web of Science ®Google Scholar
• Chae Y-J, Chang J-E, Lee M-K, et al. (2022). Regulation of drug transporters by microRNA and implications in disease treatment. J Pharm Investig 52:23–5.
   Web of Science ®Google Scholar
• Cholakova D, Glushkova D, Tcholakova S, Denkov N. (2020). Nanopore and nanoparticle formation with lipids undergoing polymorphic phase transitions. ACS Nano 14:8594–604.
   PubMed Web of Science ®Google Scholar
• Chuesiang P, Siripatrawan U, Sanguandeekul R, et al. (2018). Optimization of cinnamon oil nanoemulsions using phase inversion temperature method: impact of oil phase composition and surfactant concentration. J Colloid Interface Sci 514:208–16.
   PubMed Web of Science ®Google Scholar
• Crommelin DJ, Anchordoquy TJ, Volkin DB, et al. (2021). Addressing the cold reality of mRNA vaccine stability. J Pharm Sci 110:997–1001.
   PubMed Web of Science ®Google Scholar
• Cui L, Pereira S, Sonzini S, et al. (2022). Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery. Nanoscale 14:1480–91.
   PubMed Web of Science ®Google Scholar
• Cui L. (2015). Lipopolyplexes containing bifunctional peptides for DNA and siRNA delivery: Doctoral dissertation. England, UK: King’s College London.
   Google Scholar
• Cun D, Foged C, Yang M, et al. (2010). Preparation and characterization of poly (DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Int J Pharm 390:70–5.
   PubMed Web of Science ®Google Scholar
• Denkov N, Tcholakova S, Lesov I, et al. (2015). Self-shaping of oil droplets via the formation of intermediate rotator phases upon cooling. Nature 528:392–5.
   PubMed Web of Science ®Google Scholar
• Evans RK, Xu Z, Bohannon KE, et al. (2000). Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies. J Pharm Sci 89:76–87.
   PubMed Web of Science ®Google Scholar
• Evers MJ, Kulkarni JA, van der Meel R, et al. (2018). State-of-the-art design and rapid-mixing production techniques of lipid nanoparticles for nucleic acid delivery. Small Methods 2:1700375.
   Web of Science ®Google Scholar
• FDA. (2017). FDA ONPATTRO (patisiran) Lipid Complex Injection Addendum to Drug Product Quality Review [WWW Document]. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210922Orig1s000ChemR.pdf.
   Google Scholar
• Forigua A, Kirsch RL, Willerth SM, Elvira KS. (2021). Recent advances in the design of microfluidic technologies for the manufacture of drug releasing particles. J Control Release 333:258–68.
   PubMed Web of Science ®Google Scholar
• Golmohammadzadeh S, Mokhtari M, Jaafari MR. (2012). Preparation, characterization and evaluation of moisturizing and UV protecting effects of topical solid lipid nanoparticles. Braz J Pharm Sci 48:683–90.
   Web of Science ®Google Scholar
• Gujrati M, Malamas A, Shin T, et al. (2014). Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release. Mol Pharm 11:2734–44.
   PubMedGoogle Scholar
• Gumireddy A, Christman R, Kumari D, et al. (2019). Preparation, characterization, and in vitro evaluation of curcumin-and resveratrol-loaded solid lipid nanoparticles. AAPS PharmSciTech 20:1–14.
   Web of Science ®Google Scholar
• Hannon GJ, Rossi JJ. (2004). Unlocking the potential of the human genome with RNA interference. Nature 431:371–8.
   PubMed Web of Science ®Google Scholar
• Jones KL, Drane D, Gowans EJ. (2007). Long-term storage of DNA-free RNA for use in vaccine studies. Biotechniques 43:675–81.
   PubMed Web of Science ®Google Scholar
• Karnik R, Gu F, Basto P, et al. (2008). Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett 8:2906–12.
   PubMed Web of Science ®Google Scholar
• Kim B, Park JH, Sailor MJ. (2019). Rekindling RNAi therapy: materials design requirements for in vivo siRNA delivery. Adv Mater 31:1903637.
   PubMed Web of Science ®Google Scholar
• Kulkarni JA, Darjuan MM, Mercer JE, Chen S, et al. (2018). On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA. ACS Nano 12:4787–95.
   PubMed Web of Science ®Google Scholar
• Kumar R, Singh A, Garg N, Siril PF. (2018). Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs. Ultrason Sonochem 40:686–96.
   PubMed Web of Science ®Google Scholar
• Kundu AK, Chandra PK, Hazari S, et al. (2012). Development and optimization of nanosomal formulations for siRNA delivery to the liver. Eur J Pharm Biopharm 80:257–67.
   PubMed Web of Science ®Google Scholar
• Kwon HJ, Kim S, Kim S, et al. (2017). Controlled production of monodisperse polycaprolactone microspheres using flow-focusing microfluidic device. BioChip J 11:214–8.
   Web of Science ®Google Scholar
• Lu X, Fang C, Sheng X, et al. (2019). One-step and solvent-free synthesis of polyethylene glycol-based polyurethane as solid–solid phase change materials for solar thermal energy storage. Ind Eng Chem Res 58:3024–32.
   Web of Science ®Google Scholar
• Maugeri M, Nawaz M, Papadimitriou A, et al. (2019). Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells. Nat Commun 10:1–15.
   PubMed Web of Science ®Google Scholar
• Moderna. (2020). Moderna announces longer shelf life for its COVID-19 vaccine candidate at refrigerated temperatures. Cambridge, MA: Moderna. Inc.
   Google Scholar
• Pardi N, Hogan MJ, Porter FW, Weissman D. (2018). mRNA vaccines—a new era in vaccinology. Nat Rev Drug Discov 17:261–79.
   PubMed Web of Science ®Google Scholar
• Petrilli R, Eloy JO, de Souza MC, et al. (2016). Lipid nanoparticles as non-viral vectors for siRNA delivery: concepts and applications. In: Nanobiomaterials in drug delivery. Norwich New York, USA: Elsevier, 75–109.
   Google Scholar
• Roces CB, Lou G, Jain N, et al. (2020). Manufacturing considerations for the development of lipid nanoparticles using microfluidics. Pharmaceutics 12:1095.
   PubMed Web of Science ®Google Scholar
• Ryu S, Jin M, Lee H-K, et al. (2022). Effects of lipid nanoparticles on physicochemical properties, cellular uptake, and lymphatic uptake of 6-methoxflavone. J Pharm Investig 52:233–41.
   Web of Science ®Google Scholar
• Salminen H, Ankenbrand J, Zeeb B, et al. (2019). Influence of spray drying on the stability of food-grade solid lipid nanoparticles. Food Res Int 119:741–50.
   PubMed Web of Science ®Google Scholar
• Samaridou E, Heyes J, Lutwyche P. (2020). Lipid nanoparticles for nucleic acid delivery: Current perspectives. Adv Drug Deliv Rev 154-155:37–63.
   PubMed Web of Science ®Google Scholar
• Sato K. (2018). Crystallization of lipids: fundamentals and applications in food, cosmetics, and pharmaceuticals. Hoboken, NJ: John Wiley & Sons.
   Google Scholar
• Schoenmaker L, Witzigmann D, Kulkarni JA, et al. (2021). mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm 601:120586.
   PubMed Web of Science ®Google Scholar
• Shepherd SJ, Issadore D, Mitchell MJ. (2021). Microfluidic formulation of nanoparticles for biomedical applications. Biomaterials 274:120826.
   PubMed Web of Science ®Google Scholar
• Sriwongsitanont S, Ueno M. (2010). Effect of freeze-thawing process on the size and lamellarity of peg-lipid liposomes. Open Colloid Sci J 4(1):1–6.
   Google Scholar
• Suzuki Y, Hyodo K, Tanaka Y, Ishihara H. (2015). siRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo. J Control Release 220:44–50.
   PubMed Web of Science ®Google Scholar
• Tang M, Hu S, Hattori Y. (2020). Effect of pre‑freezing and saccharide types in freeze‑drying of siRNA lipoplexes on gene‑silencing effects in the cells by reverse transfection. Mol Med Rep 22:3233–44.
   PubMed Web of Science ®Google Scholar
• Tcholakova S, Valkova Z, Cholakova D, et al. (2017). Efficient self-emulsification via cooling-heating cycles. Nat Commun 8:15012.
   PubMed Web of Science ®Google Scholar
• Titze-de-Almeida SS, Brandão PRdP, Faber I, Titze-de-Almeida R. (2020). Leading RNA interference therapeutics part 1: silencing hereditary transthyretin amyloidosis, with a focus on patisiran. Mol Diagn Ther 24:49–59.
   PubMed Web of Science ®Google Scholar
• Trenkenschuh E, Friess W. (2021). Freeze-drying of nanoparticles: how to overcome colloidal instability by formulation and process optimization. Eur J Pharm Biopharm 165:345–60.
   PubMed Web of Science ®Google Scholar
• Tsao C-W. (2016). Polymer microfluidics: Simple, low-cost fabrication process bridging academic lab research to commercialized production. Micromachines 7:225.
   PubMed Web of Science ®Google Scholar
• Valkova Z, Cholakova D, Tcholakova S, et al. (2017). Mechanisms and control of self-emulsification upon freezing and melting of dispersed alkane drops. Langmuir 33:12155–70.
   PubMed Web of Science ®Google Scholar
• Vandamme TF, Anton N. (2010). Low-energy nanoemulsification to design veterinary controlled drug delivery devices. Int J Nanomedicine 5:867–73.
   PubMed Web of Science ®Google Scholar
• Villar-Alvarez E, Leal BH, Martinez-Gonzalez R, et al. (2019). SiRNA silencing by chemically modified biopolymeric nanovectors. ACS Omega 4:3904–21.
   Web of Science ®Google Scholar
• Westesen K, Siekmann B. (1997). Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int J Pharm 151:35–45.
   Web of Science ®Google Scholar
• Wittrup A, Ai A, Liu X, et al. (2015). Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat Biotechnol 33:870–6.
   PubMed Web of Science ®Google Scholar
• Zhang N-N, Li X-F, Deng Y-Q, et al. (2020). A thermostable mRNA vaccine against COVID-19. Cell 182:1271–83. e16.
   PubMed Web of Science ®Google Scholar
• Zhao P, Hou X, Yan J, et al. (2020). Long-term storage of lipid-like nanoparticles for mRNA delivery. Bioact Mater 5:358–63.
   PubMed Web of Science ®Google Scholar